Dashboard
Manage Tickers

VRTX VERTEX PHARMACEUTICALS INC ...

Nasdaq vrtx.com


$ 425.57 $ 5.68 (1.35 %)    

Friday, 31-Oct-2025 18:32:03 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 425.57
$ 416.28
$ 415.00 x 3
$ 427.67 x 1
$ 415.76 - $ 426.96
$ 362.50 - $ 519.88
1,499,268
na
109.11B
$ 0.55
$ 30.00
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-13-2025 12-31-2024 10-K
4 11-05-2024 09-30-2024 10-Q
5 08-02-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-15-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 02-10-2023 12-31-2022 10-K
12 10-28-2022 09-30-2022 10-Q
13 08-05-2022 06-30-2022 10-Q
14 05-06-2022 03-31-2022 10-Q
15 02-09-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 07-30-2021 06-30-2021 10-Q
18 04-30-2021 03-31-2021 10-Q
19 02-11-2021 12-31-2020 10-K
20 10-30-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 05-01-2020 03-31-2020 10-Q
23 02-13-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-01-2019 03-31-2019 10-Q
27 02-13-2019 12-31-2018 10-K
28 10-25-2018 09-30-2018 10-Q
29 07-26-2018 06-30-2018 10-Q
30 04-27-2018 03-31-2018 10-Q
31 02-15-2018 12-31-2017 10-K
32 10-30-2017 09-30-2017 10-Q
33 07-28-2017 06-30-2017 10-Q
34 04-28-2017 03-31-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 10-31-2016 09-30-2016 10-Q
37 08-01-2016 06-30-2016 10-Q
38 05-03-2016 03-31-2016 10-Q
39 02-16-2016 12-31-2015 10-K
40 10-30-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

preview-vertex-pharmaceuticalss-earnings
Preview: Vertex Pharmaceuticals's Earnings
10/31/2025 14:01:31

heres-how-much-100-invested-in-vertex-pharmaceuticals-15-years-ago-would-be-worth-today
Here's How Much $100 Invested In Vertex Ph...
10/30/2025 23:00:35

vertex-pharmaceuticals-presents-multiple-abstracts-showing-clinical-benefits-of-cftr-modulators-at-north-american-cystic-fibrosis-conference-in-seattle
Vertex Pharmaceuticals Presents Multiple A...
10/23/2025 13:06:38

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the presentation of multiple abstracts demonstrating the cli...

reported-earlier-vertex-advances-povetacicept-program-with-fda-rolling-review-for-igan-initiates-olympus-a-phase-2b3-pivotal-study-of-pove-for-the-treatment-of-pmn-and-announces-updated-date-from-ruby-3-trial-accepted-for-late-breaking-american-society-of-nephrology-2025-presentation
Reported Earlier: Vertex Advances Povetaci...
10/17/2025 15:34:58

- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vert...

vera-therapeutics-lead-kidney-drug-poised-for-2026-launch-in-multi-billion-dollar-market
Vera Therapeutics' Lead Kidney Drug Poised...
10/16/2025 18:17:37

Bank of America initiates coverage on Vera Therapeutics, citing strong potential for atacicept, its kidney treatment.

heres-how-much-100-invested-in-vertex-pharmaceuticals-10-years-ago-would-be-worth-today
Here's How Much $100 Invested In Vertex Ph...
10/14/2025 14:15:20

morgan-stanley-maintains-equal-weight-on-vertex-pharmaceuticals-lowers-price-target-to-438
Morgan Stanley Maintains Equal-Weight on V...
10/10/2025 17:32:10

Morgan Stanley analyst Terence Flynn maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Equal-Weight and lowers the price...

spotlight-on-vertex-pharmaceuticals-analyzing-the-surge-in-options-activity
Spotlight on Vertex Pharmaceuticals: Analy...
10/08/2025 18:01:11

jp-morgan-maintains-overweight-on-vertex-pharmaceuticals-raises-price-target-to-530
JP Morgan Maintains Overweight on Vertex P...
10/08/2025 17:47:34

JP Morgan analyst Jessica Fye maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and raises the price target f...

heres-how-much-you-would-have-made-owning-vertex-pharmaceuticals-stock-in-the-last-20-years
Here's How Much You Would Have Made Owning...
10/06/2025 16:15:22

servicenow-vertex-pharmaceuticals-and-more-cnbcs-final-trades
ServiceNow, Vertex Pharmaceuticals And Mor...
10/03/2025 12:23:13

Jason Snipe likes ServiceNow (NOW), down 14% YTD. Morgan Stanley upgraded to Overweight. Shannon Saccocia chose iShares Core S&...

apple-to-rally-around-17-here-are-10-top-analyst-forecasts-for-thursday
Apple To Rally Around 17%? Here Are 10 Top...
10/02/2025 18:48:46

citigroup-maintains-buy-on-vertex-pharmaceuticals-raises-price-target-to-575
Citigroup Maintains Buy on Vertex Pharmace...
10/02/2025 17:43:13

Citigroup analyst Geoff Meacham maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $...

Core News & Articles
CNBC Halftime Report Final Trades: Service...
10/02/2025 17:00:51

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/01/2025 17:35:33

what-does-the-market-think-about-vertex-pharmaceuticals-inc
What Does the Market Think About Vertex Ph...
09/30/2025 15:00:40

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
09/29/2025 17:35:29

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...

trumps-100-pharmaceutical-tariff-the-270-billion-manufacturing-war-that-could-reshape-your-medicine-cabinet
Trump's 100% Pharmaceutical Tariff: The $2...
09/26/2025 12:01:51

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creatin...

crowdstrike-to-rally-around-26-here-are-10-top-analyst-forecasts-for-thursday
CrowdStrike To Rally Around 26%? Here Are ...
09/25/2025 12:16:13

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

assessing-vertex-pharmaceuticals-insights-from-15-financial-analysts
Assessing Vertex Pharmaceuticals: Insights...
09/25/2025 12:01:13

Ratings for Vertex Pharmaceuticals (NASDAQ: VRTX) were provided by 15 analysts in the past three months, showcasing a mix of bu...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION